Jul 13 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2026 May 31, 2025 May 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.10 trln 1.01 trln 1.19 trln 582.70
(+8.7 pct) (+4.8 pct) (+8.2 pct) (+8.5 pct)
Operating 42.35 40.40 43.00 20.78
(+4.8 pct) (+28.3 pct) (+1.5 pct) (+0.5 pct)
Recurring 44.61 43.16 45.70 22.18
(+3.4 pct) (+25.8 pct) (+2.4 pct) (+1.1 pct)
Net
Net 32.05 30.98 30.70 14.48
(+3.4 pct) (+26.7 pct) (-4.2 pct) (-1.2 pct)
EPS 404.33 yen 390.86 yen 387.35 yen 182.70 yen
Ann Div 82.00 yen 70.00 yen 84.00 yen
-Q2 Div 37.50 yen 32.50 yen 42.00 yen
-Q4 Div 44.50 yen 37.50 yen 42.00 yen
NOTE - Cosmos Pharmaceutical Corp..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T